Apollo Medical Holdings Inc (ASTH) Financials

$36.72

$0.16 (0.44%)

As on 26-Apr-2024 09:30EDT

Market cap

$-- Mln

Revenue (TTM)

$1,387 Mln

P/E Ratio

--

P/B Ratio

0

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	1,386.66	1,144.16	773.92	370.25	560.62	519.91
Cost of Revenue	1,171.70	944.69	596.14	348.54	467.81	361.13
Gross Profit	214.96	199.48	177.77	21.71	92.81	158.78
Operating Expenses	1,302.05	95.21	79.59	15.62	58.40	66.55
Operating Profit (EBIT)	84.61	104.27	98.18	6.09	32.42	88.43
Other Income	--	--	--	--	--	--
Profit before Tax	89.84	86.62	77.75	8.87	25.84	82.63
Provision for Tax	--	40.88	31.69	9.18	8.17	22.36
Profit after Tax (Net Income)	60.72	45.17	68.92	-23.75	14.12	10.84
Minority Interest	2.87	-0.57	22.87	-23.44	--	--
Consolidated Profit	--	--	--	--	--	--

Liabilities ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	614.22	542.56	448.17	330.82	191.55	180.55
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	303.92	259.06	242.00	257.35	262.23	34.32
Current Liabilities	218.67	148.61	114.72	114.99	105.42	72.02
Total Liabilities	933.36	966.21	867.36	817.49	728.71	513.00

Assets ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	471.85	538.09	462.90	478.91	399.65	340.14
Current Assets	461.51	428.13	404.46	338.58	329.07	172.86
Total Assets	--	966.21	867.36	817.49	728.71	513.00
Total Debt*	--	229.36	200.98	260.56	256.55	13.66
Net Current Assets	242.83	279.52	289.74	223.59	--	--

Cashflow ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	68.23	82.13	70.34	46.16	13.67	25.50
Cash Flow from Investing Activities	--	--	--	--	--	--
Cash from Financing Activities	3.42	-20.09	-47.75	-51.70	163.33	-11.18
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	1.30	1.04	1.50	-0.64	0.38	0.07
Cash EPS ($)	1.68	1.45	1.88	-0.15	0.38	0.07
Adjusted Book Value ($)	13.11	12.52	9.76	8.88	5.22	1.17
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	1.46	1.90	1.53	1.24	0.37	0.16
Free Cash Flow per Share ($)	0.85	1.37	1.11	1.21	0.34	0.16

Profitability Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	8.76	6.36	11.11	-4.57	4.40	6.01
ROE (%)	10.50	9.12	17.70	-9.09	7.59	6.36
ROA (%)	6.39	4.93	8.18	-3.07	2.27	2.16
EBIT Margin (%)	--	10.12	12.13	5.92	5.81	16.73
Net Margin (%)	4.38	3.95	8.91	-6.42	2.52	2.08
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	0.21	0.48	1.09	-0.34	0.08	0.46
EBIT Growth (%)	--	23.35	328.32	-32.69	-62.56	131.05
Net Profit Growth (%)	34.42	-34.46	390.18	-268.26	30.28	-58.01
EPS Growth (%)	0.24	-0.31	3.35	-2.66	4.49	-0.74
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	29.55	28.39	48.93	-28.65	47.89	283.59
Price / Book Value	2.92	2.36	7.53	2.06	3.53	17.02
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	--	9.13	29.51	16.88	14.02	28.02
Close Price ($)	38.30	29.59	73.48	18.27	18.41	19.85
High Price ($)	40.81	75.23	133.23	19.68	23.26	30.00
Low Price ($)	27.55	26.89	18.26	9.27	13.02	13.01
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	--	0.42	0.45	0.79	1.34	0.08
Short term debt to equity ratio	--	0.01	0.01	0.04	0.07	0.00
Current Ratio	2.11	2.88	3.53	2.94	3.12	2.40
Quick Ratio	--	--	--	--	--	--
Interest Coverage	--	14.62	17.41	8.68	6.88	155.06

Operating Efficiency Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	9.79	10.46	12.83	16.37	17.65	11.05
Asset Turnover	1.46	1.25	0.92	0.48	0.90	1.04
Receivable days	33.65	34.96	37.74	78.71	50.95	27.25
Inventory Days	--	--	--	--	--	--
Payable days	4.30	6.69	10.80	14.74	5.84	16.85
Cash Conversion Cycle	--	--	--	--	--	--